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INTRODUCTION
Microorganisms remain as one of the most important source of pharmaceutically important
drugs (Berdy, 2005; Debbab et al., 2010; Waditee-Sirisattha et al., 2016). Among the
bacteria domain, Streptomyces genus has received considerable attention by the Scientific
community for its seemingly unmatched capability of producing useful bioactive metabolites.
The Streptomyces genus was initially proposed by Waksman and Henrici (1943); as the largest
genus of Actinobacteria, it is comprised of over 780 species with validly published names
(http://www.bacterio.cict.fr/). These gram-positive bacteria have contributed remarkably in natural
product discovery as they synthesize compounds with diverse chemical structures and biological
activities such as anticancer, antibacterial, antioxidant, antifungal, and immunosuppresants
activities (Berdy, 2005; Gallagher et al., 2010; Manivasagan et al., 2013; Ser et al., 2015a,
2016a).
Over the years, drug screening programs have been focusing on identification of terrestrial
microorganisms and investigation of their bioactive potential (Burg et al., 1979; Marcus et al.,
1999). However, these efforts have resulted in rediscovery of the known bioactive compounds.
Thus, researchers begun to venture into new and/or underexplored areas in the hope of discovering
novel, potent bioactive metabolites. The mangrove ecosystem represents one of the world’s most
dynamic environments that produces commercial forest products, supports coastal fisheries and
protects coastlines (Alongi, 2008). Factors such as fluctuations in salinity and tidal gradient are
believed to be the driving force for metabolic adaptations, which could in turn lead to production
of valuable metabolites. In fact, the growing interest in bioactive potentials of mangrove-derived
Streptomyces has been demonstrated by the isolation of Streptomyces pluripotens (Lee et al., 2014a),
S. fradiae (Prakash et al., 2015), S. cheonanensis (Mangamuri et al., 2016), and S. malaysiense (Ser
et al., 2016b).
For this study, Streptomyces sp. MUSC 125 was initially isolated from mangrove soil in the east
coast of Peninsular Malaysia (Lee et al., 2014b). As an attempt to explore the antioxidant capacity of
MUSC 125, metal-chelating assay was performed and discovered its potential in quenching ferrous
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ions with activity ranging from 10.02 to 51.14% (unpublished
data). Thus, the strain was selected for whole genome sequencing
to obtain further understanding on its genomic potential.
MATERIALS AND METHODS
Isolation and Culture of Strain MUSC 125
Streptomyces sp. MUSC 125 was isolated from Tanjung Lumpur
mangrove forest located in the city of Kuantan, State of Pahang,
in December of the year 2012 (Lee et al., 2014b). Purified cultures
were maintained on ISP medium 2 slants at room temperature
for short-term storage and as glycerol suspensions (20%, v/v) at
−80◦C for long-term storage.
Genome Sequencing and Bioinformatics
Analysis of MUSC 125
The genomic DNA of MUSC 125 was extracted with
MasterpureTM DNA purification kit (Epicentre, Illumina
Inc., Madison, WI, USA) followed by RNase (Qiagen,
USA) treatment (Ser et al., 2015b). Quality of the extracted
TABLE 1 | General features of Streptomyces sp. MUSC 125 draft genome.
Streptomyces sp. MUSC 125
Genome size (bp) 7,656,461
G+C content (%) 70.00
Genome coverage 94.0x
Contigs 164
Contigs N50 (bp) 139,282
Number of ORFs 5991
tRNA genes 68
rRNA genes (5S, 16S, 23S) 4
Bioproject ID PRJNA261099
Biosample ID SAMN03070123
Genome accession JUIG00000000
FIGURE 1 | Annotation of MUSC 125 genome using Rapid Annotation using Subsystem Technology (RAST).
DNA was examined using NanoDrop spectrophotometer
(Thermo Scientific, Waltham, MA, USA) and a Qubit version
2.0 fluorometer (Life Technologies, Carlsbad, CA, USA).
Subsequently, DNA library was prepared using NexteraTM DNA
Sample Preparation kit (Nextera, USA), while the library quality
was validated by Bioanalyzer 2100 high sensitivity DNA kit
(Agilent Technologies, Palo Alto, CA) prior to sequencing.
The genome of strain MUSC 125 was sequenced on MiSeq
platform with MiSeq Reagent Kit 2 (2 × 250 bp; Illumina
Inc., Madison, WI, USA). Following that, the paired-end reads
were trimmed and de novo assembled with CLC Genomics
Workbench version 5.1 (CLC bio, Denmark). Gene prediction
was performed using Prodigal version 2.6, whereas rRNA and
tRNA were predicted using RNAmmer and tRNAscan SE version
1.21 (Lowe and Eddy, 1997; Lagesen et al., 2007; Hyatt et al.,
2010). The assembly was uploaded for annotation to Rapid
Annotation using Subsystem Technology (RAST) (Aziz et al.,
2008).
RESULTS
Sequencing of MUSC 125 genome using Illumina technology
generated a total of 4,518,422 reads. After adapter trimming,
the reads were de novo assembled into 164 contigs using
CLC Genomics workbench. The genome size of MUSC 125
is 7,656,461 bp with G + C content of 70.00% (Table 1).
The whole genome project of MUSC 125 was deposited at
DDBJ/EMBL/GenBank under accession number JUIG00000000
and the version described in this paper is the first version
(JUIG01000000). The analyses of the draft genome identified
5991 open reading frames (ORFs), 68 tRNAs, and 4 rRNA (5S,
16S, 23S rRNA). The RAST annotation has assigned these genes
into 419 subsystems, with maximum number of genes associated
with amino acids and derivatives metabolism (8.84%), followed
by carbohydrates (6.93 %) and protein metabolism subsystems
(4.73%) (Figure 1).
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Direct Link to Deposited Data and
Information to Users
The genome sequence of Streptomyces sp. MUSC 125 (Biosample
ID: SAMN03070123) can be accessed at NCBI using the
accession number JUIG00000000. The genome project data are
also available at GenBank under the genome Bioproject ID
PRJNA261099. Users can download and use the data freely for
research purpose only with acknowledgement to us and citing
this paper as reference to the data.
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